---
$id: https://graph.org.ai/products/commodity/51202403
$type: Product
source: UNSPSC
code: "51202403"
title: "Belimumab"
class: "51202400"
classTitle: "Immunosupressant antibodies"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Belimumab

**UNSPSC Code**: 51202403
**Class**: [Immunosupressant antibodies](Immunosupressant antibodies.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoclonal antibody with the molecular formula C6714H10428O2102S52, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 73B0K5S26A, more generally known as belimumab. European Medicines Agency schedules belimumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25607. The term BELIMUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, No. 1, 2004, list 51. Most nations, for tariff and trade purposes, schedule Belimumab under HS 30021091 and SITC 54163. SMILES:. As of Q4 2014, BELIMUMAB remains US FDA's Preferred Term for this commodity. . Belimumab bears US NLM identifiers UMLS ID C1723401 and NCI Concept Code C91385.

